Absorbable Hemostats Market Revenue Projected to Reach $4.95 Billion by 2030 with 8.1% CAGR

Global Absorbable Hemostats Market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Absorbable Hemostats Market Evolve From 2026 To 2030?

The absorbable hemostats market has experienced robust expansion over the past few years. Projections indicate it will expand from $3.37 billion in 2025 to $3.63 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.8%. This historical growth can be linked to several factors, including a rise in neurosurgery and orthopedic surgery procedures, an escalating need for products that control bleeding during operations, wider acceptance of oxidized regenerated cellulose and gelatin-based hemostats, the expansion of surgical facilities and operating rooms within hospitals, and increased clinical approval of absorbable biomaterial hemostats.

The absorbable hemostats market is projected to experience substantial growth over the next few years, with an anticipated expansion to $4.96 billion by 2030, reflecting a compound annual growth rate (CAGR) of 8.1%. This projected growth within the forecast period can be attributed to several factors, including the increasing application of advanced thrombin and collagen-based formulations, a growing inclination towards minimally invasive and reconstructive surgical techniques, heightened investment in bioabsorbable and hybrid hemostat innovations, an increase in procedure volumes at ambulatory surgical centers, and a stronger focus on mitigating surgical complications and accelerating recovery times. Prominent trends for the upcoming period include the progressive development of bioengineered absorbable hemostat materials engineered for superior tissue compatibility, the expanding adoption of advanced collagen, gelatin, and thrombin-based hemostats in complex surgical interventions, a rising preference for multifunctional hemostatic products that promote rapid clot stabilization and wound healing, the broadened utilization of absorbable hemostats in minimally invasive and reconstructive surgeries, and an intensified clinical emphasis on hemostats specifically designed to reduce post-operative complications and the risks of surgical bleeding.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp

What Key Drivers Are Influencing The Growth Of The Absorbable Hemostats Market?

The absorbable hemostats market is anticipated to expand due to a rising volume of surgical procedures going forward. These procedures involve medical operations performed to treat, diagnose, or manage conditions by physically altering tissues or organs through incisions or other techniques. The increase in surgical interventions stems from a growing demand for advanced medical treatments, an aging population, and breakthroughs in surgical technology that facilitate more complex and minimally invasive operations. Absorbable hemostats are employed in surgical procedures to control bleeding and promote clot formation while being gradually absorbed by the body, thereby reducing the necessity for additional interventions and minimizing postoperative complications. For instance, in April 2025, according to the British Association of Aesthetic Plastic Surgeons, a UK-based professional organization, a total of 25,972 surgical procedures were performed in 2023, with women representing 93% of all cosmetic surgeries. Men made up the remaining 7% of these cases. Consequently, the increasing number of surgical procedures is driving the growth of the absorbable hemostats market.

Which Segment Areas Are Covered In The Absorbable Hemostats Market Analysis?

The absorbable hemostats market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types

2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats

2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products

3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats

4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder

5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations

What Key Developments And Trends Are Impacting The Absorbable Hemostats Market?

Leading companies in the absorbable hemostats market are concentrating on the development of advanced products, such as absorbable hemostatic powder, to ensure swift and effective bleeding control during surgical procedures. Absorbable hemostatic powder is a medical solution designed to manage bleeding by fostering rapid clot formation at the injury site, which the body then naturally absorbs once its function is complete. For instance, in July 2023, Baxter International Inc., a US-based healthcare company, launched PERCLOT absorbable hemostatic powder. The unique molecular structure of PERCLOT granules allows for rapid water absorption, forming a gelled adhesive matrix that establishes a mechanical barrier to stop bleeding by promoting the aggregation of platelets, red blood cells, and coagulation proteins like thrombin and fibrinogen. This capability significantly improves clinicians’ ability to manage a wider array of intraoperative bleeding, which is critical for reducing the requirement for blood transfusions, minimizing major complications, and ultimately decreasing the overall cost of care.

Which Global Companies Are Actively Competing In The Absorbable Hemostats Market?

Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Baxter International Inc., B. Braun Melsungen AG, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd., Omrix Biopharmaceuticals Inc.

Read the full absorbable hemostats market report here:

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Absorbable Hemostats Market?

North America was the largest region in the absorbable hemostats market in 2025. The regions covered in the absorbable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Absorbable Hemostats Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18777&type=smp

Browse Through More Reports Similar to the Global Absorbable Hemostats Market 2026, By The Business Research Company

Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hemostasis Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model